A Phase 4 interventional study of Ketamine infusion and PCA Ketamine in Pain, Postoperative, Opioid Use and Major Surgery, sponsored by Universidad de Antioquia. Recruiting at 1 site in Colombia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-11.
Sponsored by Universidad de Antioquia · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies testing ketamine in Pain, Postoperative — 9 open to participants now, 11 under way, 3 of them phase 3. Ketamine · Pain, Postoperative.
Among the 92 studies testing ketamine in Pain, Postoperative, this one is the 14th largest by planned enrollment, is one of 7 that started in 2025, is one of 42 in phase 4, reaches primary completion later than 1 of the 10 other live ones, and was the 78th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →9 of the 92 studies testing ketamine in Pain, Postoperative are open now, in 3 countries. Recruiting first, the newest first:
Texas Tech University Health Sciences Center · Sites in United States
Ages 18–65
Fatima Memorial Hospital · Sites in Pakistan
Ages 18–50 · Women only
University of Oklahoma · Sites in United States
Ages 18–100
Assiut University
Ages 18–60
Assiut University
Ages 20–50 · Healthy volunteers
By country, each count listing its studies:
Ketamine: first FDA approval 1970 (KETALAR). What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 16 · Phase 3 19 · Phase 4 42
First in 2001; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 78 across the 92 interventional studies. Of the 65 that completed or were terminated, 17 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 92 has an industry lead sponsor. The 10 most frequent:
Universidad de Antioquia is the lead sponsor of 81 studies on the registry; 10 are open to participants now.
Universidad de Antioquia has 7 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
7 of the studies testing ketamine in Pain, Postoperative that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07370181Phase 3Assiut UniversityKetamine Irrigation Analgesia in Laparoscopic Cholecystectomy | 2027-02-01 |
| NCT07197684Aga Khan UniversityUltrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery | 2026-12-01 |
| NCT04248205University of OklahomaKetamine for Post-operative Analgesia in Hemorrhoidectomy | 2027-01 |
| NCT06738043Tanta UniversityDexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery | 2027-04-20 |
| NCT06903819Texas Tech University Health Sciences CenterKetamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients | 2027-05 |
Add all 7 to your calendar (.ics) → With an account.
Among the 92 studies testing ketamine in Pain, Postoperative, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine whether treating pain after surgery with ketamine is more effective when administered intravenously as a continuous infusion or through a patient-controlled analgesia (PCA) pump. This study focuses on adult volunteers following major orthopedic surgery. We have two main questions to address:
Participants will be divided into two groups. One group will receive ketamine via continuous infusion, while the other will receive it through a PCA pump. Both groups will also receive a placebo (a substance that looks like the drug but contains no active ingredients), ensuring that neither group knows whether they are receiving ketamine through the PCA pump (which always contains a painkiller) or as a continuous infusion.
Participants will be assigned to one of the two groups and will receive their assigned treatment for 48 hours while hospitalized. Researchers will visit participants during their first three days in the hospital to assess their pain levels and monitor for any side effects.
Managing postoperative pain is a primary concern for patients undergoing major surgery, especially in major orthopedic surgery. Effective pain management is crucial, as uncontrolled postoperative pain can lead to prolonged hospital stays, decreased patient satisfaction, and various complications, including pulmonary and gastrointestinal issues.
Current pain management strategies emphasize multimodal analgesia, which involves using multiple medications with different mechanisms of action to minimize side effects. Ketamine has been investigated in this context and has been found effective for treating postoperative pain following major surgeries while reducing the need for opioids. However, there is still some uncertainty regarding the optimal method for administering ketamine after surgery. The aim of this trial is to compare the effectiveness of intravenous ketamine in terms of pain control, measured by numerical pain scores, and opioid consumption within the first 24 hours postoperatively using two different strategies: continuous infusion versus patient-controlled analgesia (PCA) in adults undergoing non-cardiac surgery.
For this research, two hypotheses are proposed, as the objective involves two types of outcomes related to the analgesic effectiveness of intravenous ketamine: pain measured by a numerical pain scale and opioid consumption equivalent to oral morphine.
Based on data from previous studies, it is highly likely that continuous ketamine infusion will provide similar pain control efficacy at 24 hours compared to PCA ketamine. However, the data suggests that continuous infusion may result in lower opioid consumption than PCA. Therefore, the hypotheses are as follows:
**First Hypothesis** Continuous ketamine infusion is not inferior to PCA ketamine for pain control, as measured by a numerical pain scale at 24 hours postoperatively in patients undergoing major orthopedic surgery with a high risk of severe acute pain.
**Second Hypothesis** Continuous ketamine infusion is superior to PCA ketamine in reducing opioid consumption at 24 hours postoperatively in patients undergoing major orthopedic surgery at high risk of severe acute pain.
This trial will be a triple-blind, parallel-group, pragmatic, non-inferiority controlled clinical trial focused on pain management and superiority regarding opioid use, along with other secondary outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intravenous ketamine administered as a continuous infusion.
Drug: Ketamine infusion
Intravenous ketamine administered along with opioid in a single saline bag using a Patient Controlled Analgesia pump
Drug: PCA Ketamine
A 10% ketamine solution will be prepared in a 250 cc bag of 0.9% saline (1 mg/cc) using 5 cc from a vial of ketamine that has a concentration of 50 mg/cc. The infusion will be initiated at the time of surgical site closure and will proceed as follows: a bolus of 0.35 cc/kg (equivalent to 0.35 mg/kg) will be administered, followed by a continuous infusion of 0.1 cc/kg/h (equivalent to 0.1 mg/kg/h) for up to 48 hours postoperatively. Patients in this group will have access to a PCA pump with morphine for analgesic rescue and to monitor daily opioid consumption.
A mixture of 5% ketamine and 5% morphine will be prepared in a 100 cc bag of 0.9% saline. This will be achieved by using 1 cc of a ketamine vial (50 mg/cc) and 5 cc of a morphine ampule (10 mg/cc). This results in a final concentration of 0.5 mg of ketamine and 0.5 mg of morphine per cc in the 100 cc saline bag. The pump settings will be configured as follows: * PCA (Patient-Controlled Analgesia) dose: 2 cc (which delivers 1 mg of ketamine and 1 mg of morphine) * Lockout interval: 6 minutes * Maximum dose limit: 15 doses over a 4-hour period The pump will be available for patient use for up to 48 hours postoperatively.
Also known as: Ketamine PCA
Postoperative pain
Visual Analog Scale (VAS) for dynamic (during movement) pain. The VAS for pain is a unidimensional measure of pain intensity in adults.The pain VAS is a continuous visual scale from 0 to 100 mm, with 0 mm representing "no pain" and 100 mm representing maximum pain (e.g. "worst pain imaginable").
Time frame: 24 hours after surgery
Postoperative opioid use
Daily opioid use expressed in morphine equivalents (morphine equivalent daily dose MEDD)
Time frame: 24 hours after surgery
Dynamic and rest postoperative pain
Visual Analog Scale (VAS) for dynamic and rest postoperative pain . The VAS for pain is a unidimensional measure of pain intensity in adults.The pain VAS is a continuous visual scale from 0 to 100 mm, with 0 mm representing "no pain" and 100 mm representing maximum pain (e.g. "worst pain imaginable")
Time frame: 12, 24, 48, and 72 hours after surgery
Postoperative opioid use
Daily opioid use expressed in morphine equivalents (morphine equivalent daily dose MEDD)
Time frame: 48 and 72 hours after surgery
Time to ambulation
Time measured in days for the patient to begin ambulation after surgery.
Time frame: 72 hours after surgery
Hospital stay
Days of hospital stay
Time frame: From date of randomization until the date day of discharge or date of death from any cause, whichever came first, assessed up to 36 months
Postoperative nausea and vomiting
Proportion of patients with at least one episode of nausea or vomiting after surgery
Time frame: 24 hours after surgery
Respiratory depression
Proportion of patients with any episode of respiratory rate \<8 breaths per minute accompanied by supplemental oxygen requirement higher than a simple nasal cannula; or the requirement of facial mask ventilation or tracheal intubation; or requirement of naloxone reversal
Time frame: 72 hours after surgery
Oversedation
Proportion of patients with any episode of sedation measured as a level 4 or higher using Ramsay's sedation scale
Time frame: 2, 12, 24, 48, and 72 hours after surgery
Psychomimetic symptoms
Proportion of patients with at least one of the following symptoms: * Hallucinations: Defined as any tactile, visual, auditory, or sensory experience in the absence of an appropriate stimulus, referred by the patient as real * Nightmares: Defined as any vivid dream with a negative or dysphoric emotional content
Time frame: 72 hours after surgery
Delirium
Proportion of patients diagnosed with delirium using the Confusion Assessment Method scale
Time frame: 72 hours after surgery
Hemodynamic measurements - Arterial pressure
Systolic, diastolic, and mean arterial pressure in mmHg.
Time frame: 2, 12, 24, 48, and 72 hours after surgery
Hemodynamic measurements - Heart rate
Heart rate in beats per minute.
Time frame: 2, 12, 24, 48, and 72 hours after surgery
Urinary retention
Proportion of patients with any event of impossibility for spontaneous micturition reported by the patient requiring physical measures or urinary catheter insertion for resolution
Time frame: 72 hours after surgery
Pruritus
Proportion of patients reporting any episode of itching in any body region
Time frame: 72 hours after surgery
Time to first bowel movement
Measured in time to initiation of the first passing of stool or flatus
Time frame: 72 hours after surgery
Plan to share: No — It was not approved by our Institutional Research Board.
Started Mar 2025 (actual). Primary completion is estimated for Mar 2026, 12 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 12 months is below that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ketamine
Universidad de Antioquia